Breaking News

Stevanato Group to Showcase Latest Equipment Solutions at Interphex

Will demonstrate the Plus-400 machine for visual inspection of ampoules, vials and cartridges, and an assembly benchtop.

By: Kristin Brooks

Managing Editor, Contract Pharma

At Booth 1319 at Interphex, Stevanato Group will discuss the main challenges that pharma companies encounter in visual inspection, assembly, and secondary packaging processes and introduce drivers and benefits of implementing digitalization: from performance-enhancing to improvements in accuracy, efficiency, and overall quality. 
 
The company will demonstrate the Plus-400 machine for visual inspection of ampoules, vials and cartridges, and an assembly benchtop. The inspection equipment is characterized by high-speed and high-resolution cameras for high-productivity processes, and is able to deliver real-time inspection results, also separating defective pieces by categories, according to the company. The assembly unit is ideal for the device development phase and to analyze process parameters (components processability, required forces, etc.)
 
After introducing the MAVIS platform for fully automated visual inspection of pre-fillable syringes in 2022, Stevanato Group will announce new insights regarding its Combi machine at Interphex. 
 
MAVIS Combi is an automatic visual inspection machine designed to process any glass-filled drug container, and performs superior inspection, featuring enhanced flexibility. MAVIS Combi can inspect syringes, vials, ampoules, and cartridges, switching from one format to another, and detecting with extreme accuracy particles, cosmetic defects, and closure integrity issues.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters